Ocular and central nervous system lymphoma: clinical features and diagnosis

References

• Freeman CR, Shustik C, Brisson ML, Meagher-Villemure K, Dylewski I. Primary malignant lymphoma of the central nervous system. Cancer 1986; 58:1106-Iiii.
   Google Scholar
• Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ Jr. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year moo? Cancer 1997;79:2409–2413.
   Google Scholar
• Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 1987;94: 1631–1639.
   Google Scholar
• Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer 1993;72:843–849.
   PubMed Web of Science ®Google Scholar
• Whitcup SM, De Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier M Jr, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 1993;I00:1399–1406.
   Google Scholar
• Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, Nussenblatt RB, et al. Association of interleukin Ic• in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 1997;1151157–1160.
   Google Scholar
• Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-I o in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol 1995;120:671–673.
   PubMed Web of Science ®Google Scholar
• Chan CC, Shen D, Nussenblatt RB, Boni R, Zhuang Z. Detection of molecular changes in primary intraocular lymphoma by microdissection and polymerase chain reaction. Diagn Mol Pathol 1998;7:63–64.
   Google Scholar
• Shen DF, Zhuang Z, LeHoang P. Boni R, Zheng S, Nussenblatt RB, et al. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology 1998;105:1664–1669.
   Google Scholar
• Soussain C, Merle-Beral H, Reux I, Sutton L, Fardeau C, Gerber S, et al. A single-center study of II patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases. Leuk Lymphoma 1996;23:339–345.
   PubMed Web of Science ®Google Scholar
• Cooper EL, Riker JL. Malignant lymphoma of the uveal tract. Am J Ophthalmol 1951;34:1153–1158.
   PubMed Web of Science ®Google Scholar
• Piessens WF, Schur PH, Moloney WC, Churchill WH. Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases. N Engl J Med 1973;288:176–I80.
   Web of Science ®Google Scholar
• Akpek EK, Ahmed I, Hochberg FH, Soheilian M, Dryja TP, Jakobiec FA, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999;1o6:18o5–1810.
   Google Scholar
• Qualman SJ, Mendelsohn G, Mann RB, Green WR. Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer 1983;52:878–886.
   Google Scholar
• Char DH, Ljung BM, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 1988;95:625–630.
   PubMed Web of Science ®Google Scholar
• Werner MB, Phuphanich S, Lyman GH. The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer 1995;76:1634–1642.
   Google Scholar
• Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer 1988;62: 2461–2465.
   Google Scholar
• Lutz JM, Coleman MP. Trends in primary cerebral lymphoma. Br J Cancer 1994;70:716–718.
   PubMed Web of Science ®Google Scholar
• Palexas GN, Green WR, Goldberg MF, Ding Y. Diagnostic pars plana vitrectomy report of a 21-year retrospective study. Trans Am Ophthalmol Soc 1995;93:281–308.
   PubMedGoogle Scholar
• Davis JL, Solomon D, Nussenblatt RB, Palestine AG, Chan CC. Immunocytochemical staining of vitreous cells. Indications, techniques, and results. Ophthalmology 1992;99: 250–256.
   Google Scholar
• Davis JL, Viciana AL, Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol 1997;124:362–372.
   Google Scholar
• Margolis L, Fraser R, Lichter A, Char DH. The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 1980;45:688–692.
   PubMed Web of Science ®Google Scholar
• DeAngelis LM. Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J Neurooncol 1999;43:249–257.
   PubMed Web of Science ®Google Scholar
• DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992;10:635–643.
   PubMed Web of Science ®Google Scholar
• Loeffler JS, Ervin TJ, Mauch P, Skarin A, Weinstein HJ, Canellos G, et al. Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 1985;3:49o–494.
   Google Scholar
• Forsyth PA, Yahalom J, DeAngelis LM. Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 1994;44:1473–1479.
   Google Scholar
• Sandor V, Stark-Vancs V, Pearson D, Nussenblatt R, Whitcup SM, Brouwers P, et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 1998;16:300o–3006.
   Google Scholar
• Baumann MA, Ritch PS, Hande KR, Williams GA, Topping TM, Anderson T. Treatment of intraocular lymphoma with high-dose Ara-C. Cancer 1986;57:1273–1275.
   PubMed Web of Science ®Google Scholar
• Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 1997; 115:1152–H56.
   Google Scholar
• De Smet MD, Vancs VS, Kohler D, Solomon D, Chan CC. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol 1999;83:448–451.
   Google Scholar